Haruo Sugiyama

12.6k total citations
230 papers, 7.1k citations indexed

About

Haruo Sugiyama is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Haruo Sugiyama has authored 230 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 147 papers in Molecular Biology, 85 papers in Immunology and 74 papers in Oncology. Recurrent topics in Haruo Sugiyama's work include Renal and related cancers (119 papers), Immunotherapy and Immune Responses (47 papers) and CAR-T cell therapy research (36 papers). Haruo Sugiyama is often cited by papers focused on Renal and related cancers (119 papers), Immunotherapy and Immune Responses (47 papers) and CAR-T cell therapy research (36 papers). Haruo Sugiyama collaborates with scholars based in Japan, Australia and United States. Haruo Sugiyama's co-authors include Yoshitaka Oka, Yusuke Oji, Akihiro Tsuboi, Hiroyasu Ogawa, Naoki Hosen, Kazushi Inoue, Hiroya Tamaki, Tadamitsu Kishimoto, Sumiyuki Nishida and T Yamagami and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Haruo Sugiyama

227 papers receiving 7.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Haruo Sugiyama Japan	44	4.6k	2.3k	2.2k	1.4k	1.2k	230	7.1k
Jean Soulier France	51	4.1k 0.9×	3.8k 1.6×	1.3k 0.6×	2.2k 1.5×	1.4k 1.1×	155	9.2k
Donna E. Hogge Canada	54	3.5k 0.8×	2.5k 1.1×	2.2k 1.0×	5.5k 3.8×	910 0.7×	251	9.5k
Yasuhiko Kaneko Japan	51	5.3k 1.2×	1.9k 0.8×	737 0.3×	3.3k 2.2×	1.9k 1.5×	269	10.1k
Brenda J. Weigel United States	44	1.9k 0.4×	2.3k 1.0×	1.4k 0.6×	587 0.4×	358 0.3×	164	5.8k
Angelo A. Cardoso United States	38	2.0k 0.4×	1.2k 0.5×	2.5k 1.1×	998 0.7×	586 0.5×	86	5.3k
Éric Delabesse France	38	2.5k 0.5×	1.0k 0.4×	853 0.4×	3.7k 2.5×	2.0k 1.6×	156	7.1k
CI Civin United States	37	2.4k 0.5×	1.2k 0.5×	2.5k 1.2×	3.1k 2.1×	458 0.4×	63	6.9k
Jeffrey J. Molldrem United States	46	1.6k 0.4×	3.4k 1.5×	4.1k 1.9×	3.8k 2.6×	425 0.3×	163	8.5k
JH Kersey United States	42	1.2k 0.3×	1.9k 0.8×	2.8k 1.3×	4.5k 3.1×	1.6k 1.3×	108	7.5k
Memet Aker Israel	27	1.3k 0.3×	1.5k 0.7×	1.7k 0.8×	3.6k 2.5×	700 0.6×	69	5.7k

Countries citing papers authored by Haruo Sugiyama

Since Specialization

Citations

This map shows the geographic impact of Haruo Sugiyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haruo Sugiyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haruo Sugiyama more than expected).

Fields of papers citing papers by Haruo Sugiyama

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haruo Sugiyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haruo Sugiyama. The network helps show where Haruo Sugiyama may publish in the future.

Co-authorship network of co-authors of Haruo Sugiyama

This figure shows the co-authorship network connecting the top 25 collaborators of Haruo Sugiyama. A scholar is included among the top collaborators of Haruo Sugiyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haruo Sugiyama. Haruo Sugiyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kuzuya, Teiji, Yoshihiko Tachi, Haruo Sugiyama, et al.. (2025). Biomarker-Based Responder Selection and Early Prediction of Treatment Response in Hepatocellular Carcinoma: Dynamic Changes in Alpha-Fetoprotein and Des-Gamma-Carboxy Prothrombin During Atezolizumab Plus Bevacizumab Therapy. Cancers. 17(24). 3891–3891. 1 indexed citations

Koido, Shigeo, Junichi Taguchi, Shin Kan, et al.. (2024). Dendritic cells pulsed with multifunctional Wilms’ tumor 1 (WT1) peptides combined with multiagent chemotherapy modulate the tumor microenvironment and enable conversion surgery in pancreatic cancer. Journal for ImmunoTherapy of Cancer. 12(10). e009765–e009765. 13 indexed citations

Fujiki, Fumihiro, Soyoko Morimoto, Kento Inoue, et al.. (2023). Establishment of a novel NFAT-GFP reporter platform useful for the functional avidity maturation of HLA class II-restricted TCRs. Cancer Immunology Immunotherapy. 72(7). 2347–2356. 1 indexed citations

Fujiki, Fumihiro, Akihiro Tsuboi, Soyoko Morimoto, et al.. (2020). Identification of two distinct populations of WT1-specific cytotoxic T lymphocytes in co-vaccination of WT1 killer and helper peptides. Cancer Immunology Immunotherapy. 70(1). 253–263. 7 indexed citations

Shimodaira, Shigetaka, Ryu Yanagisawa, Koichi Hirabayashi, et al.. (2019). In Vivo Administration of Recombinant Human Granulocyte Colony-Stimulating Factor Increases the Immune Effectiveness of Dendritic Cell-Based Cancer Vaccination. Vaccines. 7(3). 120–120. 10 indexed citations

Tsuboi, Akihiro, Naoya Hashimoto, Fumihiro Fujiki, et al.. (2018). A phase I clinical study of a cocktail vaccine of Wilms’ tumor 1 (WT1) HLA class I and II peptides for recurrent malignant glioma. Cancer Immunology Immunotherapy. 68(2). 331–340. 43 indexed citations

Coelho-dos-Reis, Jordana Grazziela Alves, Jing Huang, Tiffany Tsao, et al.. (2016). Co-administration of α-GalCer analog and TLR4 agonist induces robust CD8 + T-cell responses to PyCS protein and WT-1 antigen and activates memory-like effector NKT cells. Clinical Immunology. 168. 6–15. 18 indexed citations

Ohta, Tsuyoshi, Yusuke Oji, Haruo Sugiyama, et al.. (2014). The Wilms' Tumor Gene WT1 − 17AA/− KTS Splice Variant Increases Tumorigenic Activity Through Up-Regulation of Vascular Endothelial Growth Factor in an In Vivo Ovarian Cancer Model. Translational Oncology. 7(5). 580–589. 10 indexed citations

Takahara, Akitaka, Shigeo Koido, Masaki Ito, et al.. (2011). Gemcitabine enhances Wilms’ tumor gene WT1 expression and sensitizes human pancreatic cancer cells with WT1-specific T-cell-mediated antitumor immune response. Cancer Immunology Immunotherapy. 60(9). 1289–1297. 46 indexed citations

10.

Ohno, Satoshi, Yumiko Ohno, Satoru Kyo, et al.. (2010). WT1 expression correlates with angiogenesis in endometrial cancer tissue.. PubMed. 30(8). 3187–92. 9 indexed citations

11.

Oka, Yoshitaka, Akihiro Tsuboi, Fumihiro Fujiki, et al.. (2009). WT1 Peptide Vaccine as a Paradigm for “Cancer Antigen-Derived Peptide”-Based Immunotherapy for Malignancies: Successful Induction of Anti-Cancer Effect by Vaccination with a Single Kind of WT1 Peptide. Anti-Cancer Agents in Medicinal Chemistry. 9(7). 787–797. 17 indexed citations

12.

Oka, Yoshitaka, Akihiro Tsuboi, Yusuke Oji, Ichiro Kawase, & Haruo Sugiyama. (2008). WT1 peptide vaccine for the treatment of cancer. Current Opinion in Immunology. 20(2). 211–220. 90 indexed citations

13.

Jomgeow, Tanyarat, Yusuke Oji, Yoko Ikeda, et al.. (2006). Wilms’ tumor gene WT1 17AA(–)/KTS(–) isoform induces morphological changes and promotes cell migration and invasion in vitro. Cancer Science. 97(4). 259–270. 57 indexed citations

14.

Tatekawa, Toyoshi, Hiroyasu Ogawa, M Kawakami, et al.. (2006). A novel direct competitive repopulation assay for human hematopoietic stem cells using NOD/SCID mice. Cytotherapy. 8(4). 390–398. 4 indexed citations

15.

Sugiyama, Haruo. (2005). Cancer immunotherapy targeting Wilms’ tumor gene WT1 product. Expert Review of Vaccines. 4(4). 503–512. 38 indexed citations

16.

Hosen, Naoki, Masashi Yanagihara, Tsutomu Nakazawa, et al.. (2004). Identification of a gene element essential for leukemia-specific expression of transgenes. Leukemia. 18(3). 415–419. 2 indexed citations

17.

Ikegame, Kazuhiro, Yasunori Tanji, Noriyuki Kitai, et al.. (2003). Successful treatment of refractory T-cell acute lymphoblastic leukemia by unmanipulated stem cell transplantation from an HLA 3-loci mismatched (haploidentical) sibling. Bone Marrow Transplantation. 31(6). 507–510. 9 indexed citations

18.

Oka, Yoshitaka, Keiko Udaka, Akihiro Tsuboi, et al.. (2000). Cancer Immunotherapy Targeting Wilms’ Tumor Gene WT1 Product. The Journal of Immunology. 164(4). 1873–1880. 160 indexed citations

19.

Oka, Yoshitaka, et al.. (1992). Regulation of Thy-1 Gene Expression by the Methylation of the 5′ Region of Thy-1 Gene and Intracellular Regulatory Factors in Immature B Cells. Immunological Investigations. 21(3). 183–191. 5 indexed citations

20.

Oka, Yoshitaka, et al.. (1992). Transitory Expression of Thy-1 Antigen in Immature B Cell Lines. Immunological Investigations. 21(1). 85–92. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact